Zinzani P L, Mazza P, Gherlinzoni F, Bocchia M, Bendandi M, Fiacchini M, Tura S
Istituto di Ematologia L. e A. Seràgnoli, Università di Bologna, Italy.
Haematologica. 1992 Sep-Oct;77(5):435-7.
In the past several decades, scientific and therapeutic advances have transformed Hodgkin's disease from a uniformly fatal illness to one that can be treated with the expectation of long-term remission or cure in the majority of cases. Because patients now survive for long periods after treatment, various late complications are being identified. Among patients with such late complications, some have been reported to experience "very late" relapses (> 10 years). Here we document recurrences in three patients with Hodgkin's disease more than 10 years after remission.
